Health & Safety Industry Today

Image-guided Biopsy Market to Surpass USD 3386.68 million by 2030: Key Players to Focus on Expansion in Emerging Markets

Image-Guided Biopsy Market to Witness Significant Growth due to Increasing Preference for Minimally Invasive Procedures and Technological Advancements in Biopsy Devices
Published 11 July 2023

Image-Guided Biopsy Market Scope & Overview

According to SNS Insider, the Image-Guided Biopsy Market reached a valuation of USD 2,266.21 million in 2022. It is projected to reach USD 3,386.68 million by 2030, experiencing a compound annual growth rate (CAGR) of 5.15% during the forecast period from 2023 to 2030.

Image-guided biopsy is a minimally invasive procedure used to obtain tissue samples from the body for further examination and analysis. It involves the use of imaging techniques, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), or fluoroscopy, to guide the biopsy needle to the targeted area of interest. By combining real-time imaging with the biopsy procedure, image-guided biopsy allows for precise and accurate sampling of tissue from deep within the body.

Key Players Covered in Image-guided Biopsy market report are: Ethicon Endo-Surgery, Intact Medical Corporation, Galini SRL, Hologic Inc., Leica Biosystems Nussloch GmbH, C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC. & Other

Get Report Sample @ https://www.snsinsider.com/sample-request/2859

Market Analysis

The image-guided biopsy market is witnessing continuous advancements in biopsy devices, including improved needle designs, navigation systems, and sample collection techniques. These advancements aim to enhance the accuracy, safety, and efficiency of the biopsy procedures. For instance, the development of vacuum-assisted biopsy devices allows multiple tissue samples to be obtained in a single procedure, reducing the need for repeated biopsies.

Impact of Recession

Recessions can pose challenges to the image-guided biopsy market due to decreased patient volumes, budget constraints, and shifting healthcare priorities. However, amidst these challenges lie opportunities for market players to adapt, innovate, and develop cost-effective solutions. Technological advancements and the pursuit of improved efficiency and accuracy can drive market recovery once the recession eases. By understanding and navigating the impact of a recession, stakeholders in the market can position themselves for long-term success and growth in the post-recession period.

Segmentation Analysis

The image-guided biopsy market is witnessing significant growth, driven by the vacuum segment and hospitals/clinics segment. The vacuum segment's innovative vacuum-assisted biopsy techniques, coupled with the comprehensive infrastructure and expertise of hospitals and clinics, are reshaping the landscape of image-guided biopsies. As these segments continue to advance, patients can benefit from improved diagnostic accuracy and streamlined procedures.

Image-guided Biopsy Market Segmentation as Follows:

By Process:

·        Vacuum Assisted Biopsy

·        Core Needle

·        Fine Needle

By Image Guided Technology:

·        MRI

·        Ultrasound

·        Mammography

·        CT

·        X-Ray

By End User:

·        Hospitals And Clinics

·        Ambulatory Surgical Centers

·        Research and Academic Institutes

Get Free Quarterly Updates, click on the link to enquire more @ https://www.snsinsider.com/enquiry/2859

Regional Status & Analysis

The Asia Pacific region is poised to dominate the image-guided biopsy market, driven by rapid technological advancements, growing healthcare infrastructure, rising cancer prevalence, and collaborative research initiatives. As the adoption of image-guided biopsy procedures continues to rise in Asia Pacific, stakeholders have a unique opportunity to contribute to improved patient outcomes, enhanced diagnostic accuracy, and ultimately, the fight against cancer.

Conclusion

The market is poised for significant growth in the coming years. Factors such as the increasing incidence of cancer, advancements in imaging technologies, the demand for personalized medicine, the preference for minimally invasive procedures, and technological advancements in biopsy devices are expected to drive the market forward.

Frequently Asked Questions/ Key Reasons to Purchase this Report

What is the projected outlook for image-guided biopsy market growth?

·        The market for image-guided biopsy is projected to surpass USD 3386.68 million by the year 2030.

What are the major factors influencing the image-guided biopsy market?

·        The continued development and adoption of image-guided biopsy procedures have the potential to revolutionize cancer diagnosis and treatment, leading to improved patient outcomes and a better understanding of the disease.

Who are the leading players in the image-guided biopsy market?

·        Ethicon Endo-Surgery, Argon Medical Devices, Cook Medical Incorporated, Leica Biosystems Nussloch GmbH, Intact Medical Corporation, Galini SRL, Hologic Inc., Becton and Dickinson Company, Encapsule Medical Devices LLC.

Table of Content

Chapter 1 Introduction

Chapter 2 Research Methodology

Chapter 3 Market Dynamics

Chapter 4. Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)

Chapter 5 Value Chain Analysis

Chapter 6 Porter’s 5 forces model

Chapter 7 PEST Analysis

Chapter 8 Image-guided Biopsy Market Segmentation, By Process

Chapter 9 Image-guided Biopsy Market Segmentation, By Technology

Chapter 10 Image-guided Biopsy Market Segmentation, By End-user

Chapter 11 Regional Analysis

Chapter 12 Company profile

Chapter 13 Competitive Landscape

Chapter 14 Use Case and Best Practices

Chapter 15 Conclusion

Buy Image-guided Biopsy Market Report @ https://www.snsinsider.com/checkout/2859

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Other Industry News

Ready to start publishing

Sign Up today!